The launch of Pharmacy First marks a significant shift in UK healthcare. Pharmacies are taking on a more central role as the initial point of contact for patients.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh